Cargando…
Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer’s Disease
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder without a cure, despite the enormous number of investigations and therapeutic approaches. AD is a consequence of microglial responses to “damage signals”, such as aggregated tau oligomers, which trigger a neuro-inflammatory reac...
Autores principales: | Andrade, Víctor, Wong-Guerra, Maylin, Cortés, Nicole, Pastor, Gabriela, González, Andrea, Calfío, Camila, Guzmán-Martínez, Leonardo, Navarrete, Leonardo P., Ramos-Escobar, Nicolas, Morales, Inelia, Santander, Rocío, Andrades-Lagos, Juan, Bacho, Mitchell, Rojo, Leonel E., Maccioni, Ricardo Benjamín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383824/ https://www.ncbi.nlm.nih.gov/pubmed/37513872 http://dx.doi.org/10.3390/ph16070960 |
Ejemplares similares
-
Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
por: Wong-Guerra, Maylin, et al.
Publicado: (2023) -
Shilajit: A Natural Phytocomplex with Potential Procognitive Activity
por: Carrasco-Gallardo, Carlos, et al.
Publicado: (2012) -
LITERARY SUPPORT TO THE VEGETABLE ORIGIN OF SHILAJIT
por: Lal, V. K., et al.
Publicado: (1988) -
Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches
por: Morales, Inelia, et al.
Publicado: (2014) -
Shilajit: A panacea for high-altitude problems
por: Meena, Harsahay, et al.
Publicado: (2010)